Employees: NN (None)Legal category: SCA (commandite par actions)Size: PMECreation date: 2008-01-01 (18 years)Status: ActiveBusiness sector: Services administratifs combinés de bureauLocation: DOMMARTIN-SOUS-AMANCE (54770), Meurthe-et-Moselle
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
BIO2F : revenue, balance sheet and financial ratios
BIO2F is a French company
founded 18 years ago,
specialized in the sector Services administratifs combinés de bureau.
Based in DOMMARTIN-SOUS-AMANCE (54770),
this company of category PME
shows in 2022 a net income positive of 480 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2022, BIO2F generates positive net income of 480 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 151 k€ -> 480 k€.
EBITDA (2022)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-7 151 €
EBIT (2022)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-7 151 €
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
480 024 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.6 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.574%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
90.409%
Repayment capacity (2022)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.592
Solvency indicators evolution BIO2F
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
44.001
31.874
21.465
13.751
11.671
14.36
10.574
Financial autonomy
69.444
75.797
82.255
87.826
89.421
87.412
90.409
Repayment capacity
4.33
3.304
2.083
1.323
1.652
1.283
0.592
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
10.572022
2020
2021
2022
Q1: 0.06
Med: 19.36
Q3: 127.67
Good
In 2022, the debt ratio of BIO2F (10.57) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
90.41%2022
2020
2021
2022
Q1: 8.69%
Med: 43.36%
Q3: 79.94%
Excellent
In 2022, the financial autonomy of BIO2F (90.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.59 years2022
2020
2021
2022
Q1: 0.0 years
Med: 0.01 years
Q3: 3.18 years
Average-7 pts over 3 years
In 2022, the repayment capacity of BIO2F (0.59) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 107676.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
107676.19
Interest coverage (2022)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-12.935
Liquidity indicators evolution BIO2F
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
None
10948.229
8127.01
10726.759
10643.957
63946.934
107676.19
Interest coverage
-1044.193
-407.952
-541.163
-15174.13
-87.935
-131.498
-12.935
Sector positioning
Liquidity ratio
107676.192022
2020
2021
2022
Q1: 102.48
Med: 282.67
Q3: 1129.65
Excellent
In 2022, the liquidity ratio of BIO2F (107676.19) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-12.94x2022
2020
2021
2022
Q1: -14.33x
Med: 0.0x
Q3: 0.09x
Average
In 2022, the interest coverage of BIO2F (-12.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 40 days. Excellent situation: suppliers finance 40 days of the operating cycle (retail model).
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
40 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution BIO2F
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
0
0
Supplier payment term (days)
0
143
462
594
762
411
40
Positioning of BIO2F in its sector
Comparison with sector Services administratifs combinés de bureau
Valuation estimate
Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions).
This range of 470 510€ to 2 615 939€ is provided for information purposes only and requires in-depth analysis to be confirmed.
Estimated enterprise value2022
Indicative
470k€1160k€2615k€
1 160 002 €Range: 470 510€ - 2 615 939€
NAF 5 année 2022
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Services administratifs combinés de bureau)
Compare BIO2F with other companies in the same sector:
The revenue of BIO2F is not publicly disclosed (confidential accounts filed with INPI).
Is BIO2F profitable?
Yes, BIO2F generated a net profit of 480 k€ in 2022.
Where is the headquarters of BIO2F ?
The headquarters of BIO2F is located in DOMMARTIN-SOUS-AMANCE (54770), in the department Meurthe-et-Moselle.
Where to find the tax return of BIO2F ?
The tax return of BIO2F is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does BIO2F operate?
BIO2F operates in the sector Services administratifs combinés de bureau (NAF code 82.11Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart